Gene test could spare prostate cancer patients from radical surgery
NCT ID NCT07282808
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a genetic test can help decide which men with prostate cancer can safely have a less invasive treatment called focal therapy, which targets only the tumor instead of the whole prostate. Researchers will enroll 130 men and use the test to classify their cancer as low or high risk for coming back. Those with low-risk genetics will get focal therapy, while high-risk patients will be advised to have standard treatments like surgery or radiation. The goal is to see if this personalized approach keeps recurrence rates below 10%.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Decipher GC genetic test
What this could lead to
If successful, this could show that genetic profiling helps choose the right patients for focal therapy, leading to fewer side effects and better cancer control.
What could go wrong
This is an early observational study with only 130 participants. The genetic test may not accurately predict recurrence, and results may not apply to all prostate cancer patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Singapore General Hospital
RECRUITINGSingapore, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••